$MSTX news from Street Insider Mast Therapeutics (MSTX) Poloxamer 188 Gets Orphan Status Mast Therapeutics (NYSE: MSTX) Poloxamer 188 received orphan drug status from the FDA. http://bit.ly/HMpThA